All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Hypertrophic Cardiomyopathy Is at Increased Risk of Thromboembolic Events: Deficiencies of CHA(2)DS(2)-VASC Score and How to Predict

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F19%3A10402050" target="_blank" >RIV/00064203:_____/19:10402050 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11130/19:10402050

  • Result on the web

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=TZ7Cc78jlB" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=TZ7Cc78jlB</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.cjca.2019.07.004" target="_blank" >10.1016/j.cjca.2019.07.004</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Hypertrophic Cardiomyopathy Is at Increased Risk of Thromboembolic Events: Deficiencies of CHA(2)DS(2)-VASC Score and How to Predict

  • Original language description

    Patients with hypertrophic cardiomyopathy (HCM) are at increased risk of potentially catastrophic thromboembolic (TE) events that can occur without any previous clinical symptoms. Recently, the Hypertrophic Cardiomyopathy Outcome Investigators developed a model to predict TE risk in patients with HCM (HCM Risk-CVA model). In this issue of the Canadian Journal of Cardiology, He et al. describe the first external validation of the previously developed HCM Risk-CVA model for the long-term TE risk. They collected 417 patients with HCM and followed them for 3.5 years. Six percent of the patients experienced a TE end point, and the model demonstrated modest, but nevertheless potentially useful, discriminating capacity for TE events (C-index 0.67). Therefore, the authors suggest using it in clinical practice for individual prognosis and antithrombotic management.

  • Czech name

  • Czech description

Classification

  • Type

    O - Miscellaneous

  • CEP classification

  • OECD FORD branch

    30201 - Cardiac and Cardiovascular systems

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2019

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů